Candida urinary tract infection: pathogenesis
- PMID: 21498837
- DOI: 10.1093/cid/cir110
Candida urinary tract infection: pathogenesis
Abstract
Candida species are unusual causes of urinary tract infection (UTI) in healthy individuals, but common in the hospital setting or among patients with predisposing diseases and structural abnormalities of the kidney and collecting system. The urinary tract may be invaded in either an antegrade fashion from the bloodstream or retrograde via the urethra and bladder. Candida species employ a repertoire of virulence factors, including phenotypic switching, dimorphism, galvano - and thigmotropism, and hydrolytic enzymes, to colonize and then invade the urinary tract. Antegrade infection occurs primarily among patients predisposed to candidemia. The process of adherence to and invasion of the glomerulus, renal blood vessels, and renal tubules by Candida species was elegantly described in early histopathologic studies. Armed with modern molecular biologic techniques, the various virulence factors involved in bloodborne infection of the kidney are gradually being elucidated. Disturbances of urine flow, whether congenital or acquired, instrumentation of the urinary tract, diabetes mellitus, antimicrobial therapy, and immunosuppression underlie most instances of retrograde Candida UTI. In addition, bacterial UTIs caused by Enterobacteriaceae may facilitate the initial step in the process. Ascending infections generally do not result in candidemia in the absence of obstruction.
Similar articles
-
Candida urinary tract infections--epidemiology.Clin Infect Dis. 2011 May;52 Suppl 6:S433-6. doi: 10.1093/cid/cir109. Clin Infect Dis. 2011. PMID: 21498836
-
Candida urinary tract infections--epidemiology, pathogenesis, diagnosis, and treatment: executive summary.Clin Infect Dis. 2011 May;52 Suppl 6:S429-32. doi: 10.1093/cid/cir108. Clin Infect Dis. 2011. PMID: 21498835
-
[Candida urinary tract infection with special reference to ascending pyelonephritis].Hinyokika Kiyo. 1991 Sep;37(9):969-74. Hinyokika Kiyo. 1991. PMID: 1785422 Review. Japanese.
-
Candida urinary tract infections--treatment.Clin Infect Dis. 2011 May;52 Suppl 6:S457-66. doi: 10.1093/cid/cir112. Clin Infect Dis. 2011. PMID: 21498839
-
Candida urinary tract infections: treatment options.Expert Rev Anti Infect Ther. 2007 Apr;5(2):277-84. doi: 10.1586/14787210.5.2.277. Expert Rev Anti Infect Ther. 2007. PMID: 17402842 Review.
Cited by
-
Clinical significance of the isolation of Candida species from hospitalized patients.Braz J Microbiol. 2015 Mar 31;46(1):117-23. doi: 10.1590/S1517-838246120120296. eCollection 2015 Mar. Braz J Microbiol. 2015. PMID: 26221096 Free PMC article.
-
Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.BMC Infect Dis. 2019 May 21;19(1):445. doi: 10.1186/s12879-019-4065-5. BMC Infect Dis. 2019. PMID: 31113382 Free PMC article.
-
Screening the Drug:H+ Antiporter Family for a Role in Biofilm Formation in Candida glabrata.Front Cell Infect Microbiol. 2020 Feb 4;10:29. doi: 10.3389/fcimb.2020.00029. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32117803 Free PMC article.
-
Nosocomial candiduria in chronic liver disease patients at a hepatobilliary center.Indian J Crit Care Med. 2014 Sep;18(9):639-40. doi: 10.4103/0972-5229.140161. Indian J Crit Care Med. 2014. PMID: 25249753 Free PMC article. No abstract available.
-
Hibiscus sabdariffa extract inhibits in vitro biofilm formation capacity of Candida albicans isolated from recurrent urinary tract infections.Asian Pac J Trop Biomed. 2014 Feb;4(2):104-8. doi: 10.1016/S2221-1691(14)60217-3. Asian Pac J Trop Biomed. 2014. PMID: 25182280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical